X-ray and cryo-EM structures of inhibitor-bound cytochrome bc 1 complexes for structure-based drug discovery
暂无分享,去创建一个
Shaun Rawson | S. Samar Hasnain | Svetlana V. Antonyuk | Colin W. G. Fishwick | C. Fishwick | S. Antonyuk | S. Hasnain | S. Rawson | S. Muench | P. O’Neill | K. Amporndanai | Stephen P. Muench | Rachel M. Johnson | Paul M. O’Neill | Kangsa Amporndanai | Alexander H. Jamson | A. H. Jamson
[1] N. Pannu,et al. REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.
[2] Joanne M. Morrisey,et al. Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasites , 1999, Molecular microbiology.
[3] J Koepke,et al. Structure at 2.3 A resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. , 2000, Structure.
[4] Akhil B. Vaidya,et al. A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil , 1999, Antimicrobial Agents and Chemotherapy.
[5] M. Fry,et al. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). , 1992, Biochemical pharmacology.
[6] Alexei Vagin,et al. Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.
[7] F. Gamo,et al. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1. , 2012, Future medicinal chemistry.
[8] Garib N. Murshudov,et al. JLigand: a graphical tool for the CCP4 template-restraint library , 2012, Acta crystallographica. Section D, Biological crystallography.
[9] M. Rossmann,et al. Antibody-induced uncoating of human rhinovirus B14 , 2017, Proceedings of the National Academy of Sciences.
[10] S. Rawson,et al. The changing landscape of membrane protein structural biology through developments in electron microscopy , 2016, Molecular membrane biology.
[11] Ge-Fei Hao,et al. Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. , 2012, Journal of the American Chemical Society.
[12] D. Julius,et al. TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action , 2016, Nature.
[13] S. Antonyuk,et al. Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1 , 2015, Proceedings of the National Academy of Sciences.
[14] L. Esser,et al. Surface-modulated motion switch: Capture and release of iron–sulfur protein in the cytochrome bc1 complex , 2006, Proceedings of the National Academy of Sciences.
[15] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[16] Peter D Gibbons,et al. 2-Pyridylquinolone antimalarials with improved antimalarial activity and physicochemical properties , 2015 .
[17] E. Carpenter,et al. Overcoming the challenges of membrane protein crystallography , 2008, Current opinion in structural biology.
[18] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[19] G. Nixon,et al. Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era. , 2013, Future medicinal chemistry.
[20] Maojun Yang,et al. Structure of Mammalian Respiratory Supercomplex I1III2IV1 , 2016, Cell.
[21] Archie L. Smith. [13] Preparation, properties, and conditions for assay of mitochondria: Slaughterhouse material, small-scale , 1967 .
[22] D. Agard,et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.
[23] U. H. Danielson,et al. Biophysics in drug discovery: impact, challenges and opportunities , 2016, Nature Reviews Drug Discovery.
[24] P. Mastroiacovo,et al. The global burden of congenital toxoplasmosis: a systematic review. , 2013, Bulletin of the World Health Organization.
[25] L. Yu,et al. Soluble cytochrome b-c1 complex and the reconstitution of succinate-cytochrome c reductase. , 1974, The Journal of biological chemistry.
[26] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[27] David J. Fleet,et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.
[28] H. Schägger,et al. Isolation of the eleven protein subunits of the bc1 complex from beef heart. , 1986, Methods in enzymology.
[29] L. Esser,et al. Structural basis for the quinone reduction in the bc1 complex: a comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site. , 2003, Biochemistry.
[30] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[31] Sjors H.W. Scheres,et al. RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.
[32] F. Daldal,et al. X-Ray Structure of Rhodobacter Capsulatus Cytochrome bc1: Comparison with its Mitochondrial and Chloroplast Counterparts , 2004, Photosynthesis Research.
[33] Peter D Gibbons,et al. Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2) , 2012, Journal of medicinal chemistry.
[34] C. Fishwick,et al. The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design , 2017, Acta crystallographica. Section D, Structural biology.
[35] J. Hemingway,et al. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria , 2012, Proceedings of the National Academy of Sciences.
[36] Shaoxia Chen,et al. Prevention of overfitting in cryo-EM structure determination , 2012, Nature Methods.
[37] D. Veesler,et al. CryoEM structure of a prokaryotic cyclic nucleotide-gated ion channel , 2017, Proceedings of the National Academy of Sciences.
[38] Philip R. Evans,et al. How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.
[39] Garib N. Murshudov,et al. Conformation-independent structural comparison of macromolecules with ProSMART , 2014, Acta crystallographica. Section D, Biological crystallography.
[40] L. Shultz,et al. Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human Erythrocytes , 2009, Antimicrobial Agents and Chemotherapy.
[41] F. Daldal,et al. Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complex. , 2010, Biochimica et biophysica acta.
[42] Maojun Yang,et al. Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2 , 2017, Cell.
[43] Kai Zhang,et al. Gctf: Real-time CTF determination and correction , 2015, bioRxiv.
[44] Organização Mundial de Saúde,et al. World malaria report 2011 , 2011 .
[45] Sung-Hou Kim,et al. Electron transfer by domain movement in cytochrome bc1 , 1998, Nature.
[46] Sozanne R. Solmaz,et al. Structure of Complex III with Bound Cytochrome c in Reduced State and Definition of a Minimal Core Interface for Electron Transfer* , 2008, Journal of Biological Chemistry.
[47] L. Esser,et al. Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function. , 2013, Biochimica et biophysica acta.
[48] T. A. Link,et al. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. , 1998, Science.
[49] P. A. Pearson,et al. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. , 1999, Ophthalmology.
[50] Wei-Chun Kao,et al. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action , 2014, Nature Communications.
[51] Owen Johnson,et al. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.
[52] R. Yolken,et al. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis , 2012, Proceedings of the National Academy of Sciences.
[53] L. Esser,et al. Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex. , 2004, Journal of molecular biology.
[54] Joanne M. Morrisey,et al. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.
[55] J Deisenhofer,et al. Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. , 1997, Science.
[56] Leonardo G. Trabuco,et al. Molecular dynamics flexible fitting: a practical guide to combine cryo-electron microscopy and X-ray crystallography. , 2009, Methods.
[57] A. Bartesaghi,et al. 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition , 2016, Science.
[58] L. Esser,et al. Inhibitor-complexed Structures of the Cytochrome bc1 from the Photosynthetic Bacterium Rhodobacter sphaeroides* , 2008, Journal of Biological Chemistry.
[59] J. Boothroyd,et al. Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance. , 2000, Molecular and biochemical parasitology.
[60] B. Trumpower,et al. Purification of a three-subunit ubiquinol-cytochrome c oxidoreductase complex from Paracoccus denitrificans. , 1986, The Journal of biological chemistry.
[61] P. Mitchell,et al. Possible molecular mechanisms of the protonmotive function of cytochrome systems. , 1976, Journal of theoretical biology.
[62] E. Berry,et al. Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: a new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. , 2005, Journal of molecular biology.
[63] G. Shanks,et al. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.